Project Details
| Status | Active |
|---|---|
| Effective start/end date | 07/12/13 → 09/3/26 |
Funding
- Northwest Biotherapeutics: $141,588.60
A Phase III Clinical Trial Evaluating DCVax-L, Autologous Dendritic Cells Pulsed With Tumor Lysate Antigen for the Treatment of Glioblastoma Multiforme (GBM)
- Davis, Raphael (PI)
- Gutman, Frederick (CoPI)
- Kowalska, Agnieszka (CoPI)
- Galler, Robert (CoPI)
- Rosiello, Arthur (CoPI)
- Woo, Henry (CoPI)
Project: Research